首页> 外文期刊>Journal of Drug Delivery and Therapeutics >DEVELOPMENT AND EVALUATION OF PRASUGREL HYDROCHLORIDE FLOATING TABLETS
【24h】

DEVELOPMENT AND EVALUATION OF PRASUGREL HYDROCHLORIDE FLOATING TABLETS

机译:普拉格雷盐酸盐漂浮片的研制与评价

获取原文
           

摘要

The objective of the present work was to formulate and characterize floating drug delivery system of Prasugrel hydrochloride that releases the drug slowly up to 8 h in order to minimize its potential side effect bleeding and to improve the bioavailability with enhance patient compliance. Prasugrel floating tablets were prepared by effervescent approach with melt granulation and direct compression techniques alone and in combination using Hydroxypropyl methylcellulose (HPMC) K100M and Compritol 888 ATO at different concentrations (20%, 30% and 40% w/w) alone and in combination. Sodium bicarbonate at concentration 10% w/w was optimized as gas generating floating agent. Evaluations were carried out on physical parameters, floating behavior and influence of type of polymer on drug release rate. All the formulations were subjected to various quality control and in-vitro dissolution studies and corresponding dissolution data were fitted to popular release kinetic equations in order to evaluate release mechanisms and kinetics. All the prasugrel floating tablet formulations followed zero order kinetics. As per Korsmeyer-Peppas equation, the release exponent “n” ranged 0.550-0.776 indicating that drug release from all the formulations was by non-Fickian diffusion mechanism. Based on the results, prasugrel hydrochloride floating tablets prepared by employing combination of 15% w/w HPMC K100M and 15% w/w Compritol 888 ATO offered desired in-vitro floating time and drug dissolution profile.
机译:本工作的目的是制定和表征普拉格雷盐酸盐的浮动药物输送系统,该系统缓慢释放药物直至8小时,以最大程度地减少其潜在的副作用出血并提高生物利用度并增强患者依从性。普拉格雷悬浮片通过泡腾法,熔融制粒和直接压片技术单独制备,以及分别使用羟丙基甲基纤维素(HPMC)K100M和Compritol 888 ATO以不同浓度(20%,30%和40%w / w)组合使用。优化了浓度为10%w / w的碳酸氢钠作为产生气体的漂浮剂。对物理参数,漂浮行为以及聚合物类型对药物释放速率的影响进行了评估。所有制剂均经过各种质量控制和体外溶出度研究,并将相应的溶出度数据拟合至流行的释放动力学方程式,以评估释放机理和动力学。所有普拉格雷悬浮片制剂均遵循零级动力学。根据Korsmeyer-Peppas方程,释放指数“ n”为0.550-0.776,表明所有制剂的药物释放都是通过非Fickian扩散机制进行的。根据结果​​,通过使用15%w / w HPMC K100M和15%w / w Compritol 888 ATO的组合制备的盐酸普拉格雷浮片,提供了所需的体外漂浮时间和药物溶出曲线。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号